OneSource Specialty Pharma Inc — Quarterly Results & Earnings

₹1473.30

+8.47%

Profit Growth YoY127.55%Latest quarter

Sales Growth YoY12.49%Latest quarter

Sales CAGR 5YN/A5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth+127.55%

🔥 Exceptional growth

YoY Sales Growth+12.49%

✅ Strong growth

OPM 5Y Average

Operating profit margin

8.21%

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

1.87

ROE

3.34%

ROCE

5.52%

💡

Growth Analysis

OneSource Specialty Pharma Inc reported YoY profit growth of 127.55% and revenue growth of 12.49% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at N/A and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on OneSource Specialty Pharma Inc

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.